Quent Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $230K | Buy |
438
+39
| +10% | +$20.5K | 0.02% | 249 |
|
|
2025
Q1 | $253K | Sell |
399
-22
| -5% | -$14K | 0.03% | 215 |
|
|
2024
Q4 | $300K | Buy |
421
+2
| +0.5% | +$1.43K | 0.03% | 194 |
|
|
2024
Q3 | $440K | Buy |
419
+8
| +2% | +$8.4K | 0.04% | 197 |
|
|
2024
Q2 | $432K | Buy |
411
+21
| +5% | +$22.1K | 0.05% | 185 |
|
|
2024
Q1 | $375K | Buy |
390
+19
| +5% | +$18.3K | 0.04% | 212 |
|
|
2023
Q4 | $326K | Buy |
371
+14
| +4% | +$12.3K | 0.04% | 216 |
|
|
2023
Q3 | $294K | Buy |
357
+24
| +7% | +$19.8K | 0.05% | 215 |
|
|
2023
Q2 | $239K | Buy |
333
+7
| +2% | +$5.03K | 0.04% | 244 |
|
|
2023
Q1 | $268K | Buy |
326
+3
| +0.9% | +$2.46K | 0.05% | 224 |
|
|
2022
Q4 | $233K | Buy |
323
+15
| +5% | +$10.8K | 0.04% | 237 |
|
|
2022
Q3 | $212K | Buy |
308
+4
| +1% | +$2.75K | 0.04% | 238 |
|
|
2022
Q2 | $180K | Sell |
304
-17
| -5% | -$10.1K | 0.04% | 248 |
|
|
2022
Q1 | $224K | Sell |
321
-922
| -74% | -$643K | 0.04% | 255 |
|
|
2021
Q4 | $785K | Buy |
+1,243
| New | +$785K | 0.17% | 104 |
|